It is white solid in appearance, CAS number is 68401-82-1, and the molecular formula is C13H12N5O5S2.na.

Market Analysis and Insights: Global Ceftizoxime Sodium API Market
The global Ceftizoxime Sodium API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Ceftizoxime Sodium API Scope and Market Size
The global Ceftizoxime Sodium API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ceftizoxime Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Ceftizoxime Sodium Injection
Other

The Ceftizoxime Sodium API market is analysed and market size information is provided by regions (countries). Segment by Application, the Ceftizoxime Sodium API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sterile India
Hangzhou Viwa
Sinopharm Weiqida Pharmaceutical
Qilu Pharmaceutial
Orchid Pharma
Parabolic Drugs
Luoxin Pharmaceutical
Hanmi Fine Chemical
SPC Pharma
Shamshree Lifesciences